SCHEMBL27739396

SCHEMBL27739396

Cc1cc(-c2ccc(Cl)c(C)c2)n(Cc2ccccc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 3/20 0.44
▸ HDAC4 P56524 3/20 0.44
▸ HDAC1 Q13547 3/20 0.44
▸ HDAC7 Q8WUI4 3/20 0.44
▸ HDAC2 Q92769 3/20 0.44
▸ HDAC10 Q969S8 3/20 0.44
▸ HDAC11 Q96DB2 3/20 0.44
▸ HDAC8 Q9BY41 3/20 0.44
▸ HDAC6 Q9UBN7 3/20 0.44
▸ HDAC9 Q9UKV0 3/20 0.44
▸ HDAC5 Q9UQL6 3/20 0.44
▸ NCOR2 Q9Y618 3/20 0.44
▸ MALT1 Q9UDY8 1/20 0.44
▸ KCNH2 Q12809 1/20 0.43
▸ MARS1 P56192 1/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ DRD4 P21917 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ GRIN1 Q05586 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27759621 0.84 CNR2 (0.48) MALT1MARS1POLBGRIN1GRIN2B
SCHEMBL4429627 0.81 MALT1 (0.55) MALT1MARS1CNR2SLC16A3SLC16A1
SCHEMBL3489723 0.79 HDAC6 (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5902998 0.74 CNR2 (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2828428 0.74 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8366415 0.73 MARS1 (0.53) MALT1MARS1CNR2
SCHEMBL8369153 0.73 MARS1 (0.53) MALT1MARS1CNR2
Hydrochloric Acid SCHEMBL8369717 0.73 CNR2 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL3322508 0.73 LMNA (0.61) POLBALDH1A1LMNAPTGS2GAA
SCHEMBL5903036 0.71 CNR2 (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101431998-A Containing CBxPharmaceutical compositions of cannabinoid receptor modulators and potassium channel modulators SOLVAY PHARM GMBH (DE) 2009-05-13 — — CN disclosed
Send feedback